moricizine has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Chow, MS; Fan, C; Kluger, J; O'Rangers, EA; Ujhelyi, MR | 1 |
Furuno, I; Mitamura, H; Ogawa, S; Okada, Y; Sadanaga, T; Tsutsumi, N; Yoshimoto, T | 1 |
Berdiaev, SIu; Darinskiĭ, NV; Kaverina, NV; Rodionov, AP; Shestakova, NV | 1 |
4 other study(ies) available for moricizine and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Antifibrillatory and electrophysiologic actions of moricizine alone and in combination with lidocaine: a prospective, randomized trial.
Topics: Animals; Blood Pressure; Disease Models, Animal; Double-Blind Method; Electrocardiography; Lidocaine; Moricizine; Prospective Studies; Random Allocation; Swine; Ventricular Fibrillation | 1993 |
Rate-dependent anisotropic conduction property in the epicardial border zone of canine myocardial infarcts and its modification by moricizine.
Topics: Analysis of Variance; Animals; Anisotropy; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Electric Stimulation; Female; Heart; Heart Conduction System; Injections, Intravenous; Male; Moricizine; Myocardial Infarction; Myocardium; Tachycardia, Ventricular | 1995 |
[Correlation between the anti-arrhythmia effect of ethacizin and pharmacokinetic parameters in a model of rhythm adoption by the heart].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biological Availability; Cats; Disease Models, Animal; Drug Evaluation, Preclinical; Half-Life; Kinetics; Moricizine; Phenothiazines; Time Factors | 1986 |